Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8839716 | Brain Research | 2018 | 7 Pages |
Abstract
Niemann-Pick Type C1 (NPC1) disease is an autosomal recessive neurodegenerative disease characterized by an excessive accumulation of unesterified cholesterol in late endosomes/lysosomes. Patients with NPC1 disease show a series of symptoms in neuropathology, including a gradually increased loss of motor control and seizures. However, mechanism of the neurological manifestations in NPC1 disease is not fully understood yet. In this study, we utilized the micro-electrode array (MEA) to analyze the spontaneous extracellular electrical activity in cultivated cortical neurons of the NPC1 mutant (NPC1â/â) mouse. Our results show a decrease of the spontaneous electrical activity in NPC1â/â neuronal network when compared to wild type neurons, as indicated by the decreased spike rate, burst rate, event rate, and the increased burst period and event period. Application of 3,5-dihydroxyphenylglycine (DHPG), a specific agonist of group I metabotropic glutamate receptors, improved the electrical activity of the NPC1â/â neuronal network, suggesting that DHPG can be used as a potential therapeutic strategy for recovery of the electrical activity in NPC1 disease.
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Xiao Feng, Benjamin M. Bader, Fan Yang, Monica Segura, Luise Schultz, Olaf H.-U. Schröder, Arndt Rolfs, Jiankai Luo,